These guidelines – an update to the World Health Organization’s 2015 publication Consolidated strategic information guidelines – present a set of essential aggregate indicators and guidance on choosing, collecting and systematically analysing strategic information to manage and monitor the nat...ional health sector response to HIV.
more
Meeting Report
27–30 June 2017 Manila, Philippines
AACAP OFFICIAL ACTION | This Practice Parameter identifies best approaches to the assessment and management of children and adolescents across all phases of a disaster. Delivered within a disaster system of care, many interventions are appropriate for implementation in the weeks and months after a d...isaster. These include psychological first aid, family outreach, psychoeducation, social support, screening, and anxiety reduction techniques. The clinician should assess and monitor risk and protective factors across all phases of a disaster. Schools are a natural site for conducting assessments and delivering services to children. Multimodal approaches using social support, psychoeducation, and cognitive behavioral techniques have the strongest evidence base. Psychopharmacologic interventions are not generally used but may be necessary as an adjunct to other interventions for children with severe reactions or coexisting psychiatric conditions
more
Towards the Elimination of Mother-to-Child Transmission of HIV and keeping mothers Alive. 2012-2015
Gurejeet al. BMC Health Services Research (2015) 15:242
DOI 10.1186/s12913-015-0911-3
22nd edition
Each of the 20 chapters deals with aspects of the UHC journey, dedicated towards an equitable and inclusive national health system that leaves no-one behind. While some authors describe the fundamental changes and practical considerations required to reconfigure the country's health sy...stem, others have reflected on specific programmatic areas and have made recommendations from a National Health Insurance (NHI)/UHC lens.
In addition, we are pleased to announce that this year's edition includes two innovations. First is the provision of concise summaries of the chapters in the form of 'chapters at a glance'. These are positioned together at the start of the publication for ease of reference and to give a quick overview. The second innovation is the introduction of our Healthcare Workers' Writing Programme (HCWWP), which provides support to first-time authors wanting to publish in the Review.
more
Disposer d’une information sanitaire de qualité est une quête
permanente de la DGESS du Ministère de la santé. Le niveau de
qualité des données de routine du système national d’information
sanitaire bien qu’en amélioration ces dernières années demeure une
priorité. Une des cause...s évoquée souvent pour justifier la faible qualité
des données est l’insuffisance de compétence des acteurs chargés de
la collecte et du rapportage des données dans les différentes
structures de soins. L’absence de formation des acteurs sur le SNIS
implique des erreurs de remplissage, de rapportage d’une part et
d’autre part une méconnaissance de l’intérêt des données de qualité
dans la prise de décision. Bien que cette justification soit fondée, on
est à même à se demander si c’est l’unique cause de la faible qualité des données. Certainement
pas. Le sens de la responsabilité et de l’intérêt porté à la qualité des données par les différents
acteurs aux différents niveaux influence la qualité des données. Imaginons un seul instant où chaque
mois, chaque responsable de structure, chaque acteur du SNIS apprécie la complétude, la qualité
d’un certain nombre d’indicateur. Le feedback qui sera fait contribuera à rehausser un tant soit peu la
qualité des données. Nous osons croire que cet exercice sera le quotidien de tout un chacun d’entre
nous. Engageons-nous dès à présent pour la qualité des données. Tout en vous donnant rendezvous au prochain numéro, je réitère mes encouragements à l’ensemble des acteurs du SNIS pour le
travail abattu au quotidien et aux partenaires pour leur soutien inconditionnel à la réalisation de nos
activités. Je souhaite à toutes et à tous, une très bonne lecture.
more
Since the start of the pandemic, the region has been hit by multiple natural and biological disasters. At the same time, climate change has continued to warm the world, exacerbating the impacts of many of these disasters. The *Asia-Pacific Disaster Report 2021, *also launched today, shows that the p...andemic, combined with the persistent reality of climate change, has reshaped and expanded the disaster “riskscape” in Asia and the Pacific.
more
The Compendium of data and evidence-related tools for use in TB planning and programming was developed as a companion document to the People-centred framework for tuberculosis programme planning and prioritization – user guide, published by the World Health Organization (WHO)... in 2019. The compendium is intended to support implementation of the people-centred framework user guide. It can also be used independently to inform decisions taken by national tuberculosis (TB) programmes about the implementation of the tools included in this document.
more
A rapid review of evidence on the managing the risk of disease emergence in the wildlife trade - World Animal Health Organization (OIE)
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...ractical tools to
support cholesterol advocacy at the local and regional levels.
more
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma...tive therapy - and therefore where needs are not being met. Therefore, this study aims to define gaps in access to CF treatment. The results show that a significant CF patient burden exists in countries where disease-modifying drugs are unavailable, and final figures are likely underestimates. This analysis shows the potential to improve rates of diagnosis and treatment for CF, so a higher percentage of patients receive the most effective triple combination treatment.
more